Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam

eating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam Review (2803) Total Article Views Authors: Pacha O, Hebert AA Published Date May 2012 Volume 2012:5 Pages 39 - 42 DOI: http://dx.doi.org/10.2147/CCID.S23269 Received: 22 December 2011 Accepted: 01 February 2012 Published: 07 May 2012 Omar Pacha, Adelaide A Hebert Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA Abstract: Advances in current understanding of the pathophysiology of atopic dermatitis have led to improved targeting of the structural deficiencies in atopic skin. Ceramide deficiency appears to be one of the major alterations in atopic dermatitis and the replenishment of this epidermal component through topically applied ceramide based emollients appears to be safe, well tolerated, and effective. Recently a ceramide hyaluronic acid foam has become commercially available and increasing evidence supports its safety and efficacy in patients who suffer from atopic dermatitis.